Dapagliflozin (Forxiga) is the first SGLT-2 inhibitor proven to significantly reduce the risk of Cardiovascular death and hospitalisation for heart failure in patients with
Breaking News:
- Oasis Fertility Felicitates Senior Doctors During ART Conclave-2021
- BenQ unlocks Premium Home Cinema Experience, Launches V7050i – 4K Laser TV Projector
- Veranda acquires Edureka for Rs. 245 crores
- Lido Learning appoints OYO’s Jagnoor Singh as Chief Business Officer, Global
- LenDenClub selected for ‘Microsoft for Startups’; aims to minimise NPAs and Frauds